Memorial Sloan Kettering Awarded Prestigious NCI Grant to Further Advance CAR T Cell Treatments for Solid Tumors
March 19, 2024
March 19, 2024
NEW YORK, March 19 -- The Memorial Sloan Kettering Cancer Center issued the following news release:
A team at Memorial Sloan Kettering Cancer Center (MSK) led by thoracic surgeon Prasad Adusumilli, MD, has been awarded a distinguished UG3/UH3 grant from the National Cancer Institute (NCI) to advance research and testing of chimeric antigen receptor (CAR) T cell therapy for solid tumors. This funding will support Investigational New Drug (IND) studies, U.S. Food and Drug Administrati . . .
A team at Memorial Sloan Kettering Cancer Center (MSK) led by thoracic surgeon Prasad Adusumilli, MD, has been awarded a distinguished UG3/UH3 grant from the National Cancer Institute (NCI) to advance research and testing of chimeric antigen receptor (CAR) T cell therapy for solid tumors. This funding will support Investigational New Drug (IND) studies, U.S. Food and Drug Administrati . . .